Patient-Specific Glucose Prediction With Context-Aware Insulin Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing infusion pump systems struggle to provide personalized and context-sensitive glucose control due to variations in insulin response and patient-specific factors, leading to inconsistent therapy efficacy.

Innovation Solution

A patient-specific database system that utilizes a directed graph data structure to analyze historical patient data, medical records, and insurance claims data to establish causal relationships, enabling personalized predictions and recommendations through machine learning and natural language processing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If a standardized insulin infusion protocol is used, then device complexity is reduced and ease of operation is improved, but therapy efficacy and glucose control consistency deteriorate due to individual patient variations

Engineering Contradiction:
Improveease of operationVSAvoidtherapy efficacy
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The system dynamically adjusts insulin infusion parameters (rate, timing, dosage) based on real-time glucose measurements and patient-specific response patterns. The protocol transitions from fixed standardized values to adaptive parameters that change according to measured physiological states, resolving the contradiction between operational simplicity and therapy effectiveness.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system implements continuous feedback loops where glucose measurements from sensors inform subsequent insulin delivery decisions. The closed-loop control mechanism uses measured glucose levels to automatically adjust infusion rates, creating a self-regulating system that maintains glucose control without requiring complex manual intervention from patients or providers.

Inventive Principle:
Principle #23Feedback

2Reliability

If multiple patient-specific variables and contextual factors are incorporated into the control system, then therapy efficacy and personalization are improved, but device complexity and data processing requirements increase

Engineering Contradiction:
Improvetherapy efficacyVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system segments the complex control problem into distinct functional modules: glucose sensing, data storage, pattern recognition algorithms, insulin delivery control, and user interface. Each module handles specific aspects of the therapy, allowing the overall complex system to be managed through modular components that can be independently optimized and maintained.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system introduces an intelligent software intermediary layer that processes complex patient data, historical patterns, and contextual information to generate simplified control decisions. This software mediator translates complex multi-variable analysis into straightforward pump control commands, shielding the physical hardware from the full complexity of the decision-making process.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If real-time glucose monitoring and continuous adjustment are implemented, then glucose control precision is improved, but energy consumption and measurement frequency requirements increase

Engineering Contradiction:
Improveglucose control precisionVSAvoidenergy consumption
Core Design Contradiction:
Measurement precisionVSUse of energy by moving object

Solution Approach 1:

The system employs periodic glucose measurements at strategically determined intervals rather than truly continuous monitoring. The measurement frequency is dynamically adjusted based on glucose stability, recent changes, and predicted future states, allowing the system to maintain control precision while reducing unnecessary sensor activation and energy consumption during stable periods.

Inventive Principle:
Principle #19Periodic action

Data Source

PatentUS12514513B2Patient-specific glucose prediction systems and methods
Publication Date: 2026.01.06 MEDTRONIC MINIMED INC
  • US12514513B2 patent drawing
  • US12514513B2 patent drawing
  • US12514513B2 patent drawing

AI summary

Infusion devices and related medical devices, patient data management systems, and methods are provided for monitoring a physiological condition of a patient. An exemplary method of monitoring a physiological condition of a patient involves obtaining current measurement data for the physiological condition of the patient provided by a sensing arrangement, obtaining a user input indicative of one or more future events associated with the patient, and in response to the user input, determining a prediction of the physiological condition of the patient in the future based at least in part on the current measurement data and the one or more future events using one or more prediction models associated with the patient, and displaying a graphical representation of the prediction on a display device.